Financial News · Live Terminal

Page 206 of 226

Natera Insider Sold Shares Worth $1,191,775, According to a Recent SEC Filing

Steven Leonard Chapman, Director, Chief Executive Officer and President, on April 27, 2026, sold 5,838 shares in Natera (NTRA) for $1,191,775. Following the Form 4 filing with the SEC, Chapman has control over a total of 150,769 common shares of the company, with 150,769 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1604821/000171196826000010/xslF345X05/form4-04292026_090410.xml

$NTRA

Insider Trading146d ago

Natera Insider Sold Shares Worth $1,001,645, According to a Recent SEC Filing

Michael Burkes Brophy, Chief Financial Officer, on April 27, 2026, sold 5,063 shares in Natera (NTRA) for $1,001,645. Following the Form 4 filing with the SEC, Brophy has control over a total of 58,291 common shares of the company, with 58,291 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1604821/000169736226000008/xslF345X05/form4-04292026_090402.xml

$NTRA

Insider Trading146d ago

Kratos Defense & Security Solutions Insider Sold Shares Worth $431,451, According to a Recent SEC Filing

Steven S. Fendley, President, US Division, on April 27, 2026, sold 7,000 shares in Kratos Defense & Security Solutions (KTOS) for $431,451. Following the Form 4 filing with the SEC, Fendley has control over a total of 351,039 common shares of the company, with 351,039 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1069258/000169543426000006/xslF345X05/primary_doc.xml

$KTOS

Insider Trading146d ago

Revolution Medicines Insider Sold Shares Worth $413,129, According to a Recent SEC Filing

Anthony Mancini, Chief Global Commercialization Officer, on April 27, 2026, sold 3,120 shares in Revolution Medicines (RVMD) for $413,129. Following the Form 4 filing with the SEC, Mancini has control over a total of 54,400 common shares of the company, with 54,400 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1628171/000161071726000158/xslF345X05/form4.xml

$RVMD

Insider Trading146d ago

Gilead Sciences Insider Sold Shares Worth $1,291,608, According to a Recent SEC Filing

Daniel Patrick O'Day, Director, Chairman & CEO, on April 28, 2026, sold 10,000 shares in Gilead Sciences (GILD) for $1,291,608. Following the Form 4 filing with the SEC, O'Day has control over a total of 632,567 common shares of the company, with 632,567 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/882095/000163864326000020/xslF345X05/wk-form4_1777499620.xml

$GILD

Insider Trading146d ago

Intuitive Surgical Insider Sold Shares Worth $291,887, According to a Recent SEC Filing

Amy L Ladd, Director, on April 28, 2026, sold 619 shares in Intuitive Surgical (ISRG) for $291,887. Following the Form 4 filing with the SEC, Ladd has control over a total of 120 common shares of the company, with 120 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035267/000178175026000002/xslF345X05/edgardoc.xml

$ISRG

Insider Trading146d ago

SLB Insider Sold Shares Worth $1,412,000, According to a Recent SEC Filing

Olivier Le Peuch, Director, Chief Executive Officer, on April 29, 2026, sold 25,000 shares in SLB (SLB) for $1,412,000. Following the Form 4 filing with the SEC, Le Peuch has control over a total of 1,391,328 common shares of the company, with 1,391,328 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/87347/000008734726000075/xslF345X05/form4.xml

$SLB

Insider Trading146d ago

Uwm Holdings Insider Sold Shares Worth $7,113,126, According to a Recent SEC Filing

Ishbia Mat, 10% Owner, Director, President, and CEO, on April 28, 2026, sold 1,987,218 shares in Uwm Holdings (UWMC) for $7,113,126. Following the Form 4 filing with the SEC, Mat has control over a total of 3,739,864 Class A common shares of the company, with 408,131 shares held directly and 3,331,733 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1783398/000184179426000067/xslF345X05/wk-form4_1777496060.xml

$UWMC

Insider Trading146d ago

Kiniksa Pharmaceuticals International Insider Sold Shares Worth $656,260, According to a Recent SEC Filing

Barry D Quart, Director, on April 28, 2026, sold 13,099 shares in Kiniksa Pharmaceuticals International (KNSA) for $656,260. Following the Form 4 filing with the SEC, Quart has control over a total of 12,546 Class A ordinary shares of the company, with 12,546 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1730430/000138424326000010/xslF345X05/form4-04292026_080403.xml

$KNSA

Insider Trading146d ago

Verisign Insider Sold Shares Worth $1,355,107, According to a Recent SEC Filing

Danny R McPherson, Executive Vice President, Technology and Chief Security Officer, on April 28, 2026, sold 5,000 shares in Verisign (VRSN) for $1,355,107. Following the Form 4 filing with the SEC, McPherson has control over a total of 35,195 common shares of the company, with 35,195 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1014473/000194098726000012/xslF345X05/wk-form4_1777495578.xml

$VRSN

Insider Trading146d ago

Maplight Therapeutics Insider Sold Shares Worth $1,347,066, According to a Recent SEC Filing

Anatol Kreitzer, Chief Discovery Officer, on April 27, 2026, sold 45,422 shares in Maplight Therapeutics (MPLT) for $1,347,066. Following the Form 4 filing with the SEC, Kreitzer has control over a total of 211,190 voting common shares of the company, with 211,190 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123826000008/xslF345X05/form4-04292026_040429.xml

$MPLT

Insider Trading146d ago

Maplight Therapeutics Insider Sold Shares Worth $2,087,687, According to a Recent SEC Filing

Jonathan Gillis, Chief Administrative and Accounting Officer and Principal Accounting Officer, on April 27, 2026, sold 69,835 shares in Maplight Therapeutics (MPLT) for $2,087,687. Following the Form 4 filing with the SEC, Gillis has control over a total of 181,219 voting common shares of the company, with 181,219 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000170995426000008/xslF345X05/form4-04292026_040431.xml

$MPLT

Insider Trading146d ago

Robinhood Markets Insider Sold Shares Worth $489,687, According to a Recent SEC Filing

Jeffrey Tsvi Pinner, Chief Technology Officer, on April 27, 2026, sold 5,835 shares in Robinhood Markets (HOOD) for $489,687. Following the Form 4 filing with the SEC, Pinner has control over a total of 12,171 Class A common shares of the company, with 12,171 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1783879/000204907726000013/xslF345X05/wk-form4_1777494653.xml

$HOOD

Insider Trading146d ago

United Therapeutics Insider Sold Shares Worth $5,396,353, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on April 28, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,396,353. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 679,797 common shares of the company, with 40,513 shares held directly and 639,284 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000042/xslF345X05/primarydocument.xml

$UTHR

Insider Trading146d ago

Cytokinetics Insider Sold Shares Worth $447,150, According to a Recent SEC Filing

Robert I Blum, Director, President & CEO, on April 29, 2026, sold 7,500 shares in Cytokinetics (CYTK) for $447,150. Following the Form 4 filing with the SEC, Blum has control over a total of 411,996 common shares of the company, with 407,830 shares held directly and 4,166 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1061983/000106198326000044/xslF345X05/form4.xml

$CYTK

Insider Trading146d ago

Travelers Companies Insider Sold Shares Worth $483,670, According to a Recent SEC Filing

William H Heyman, Vice Chairman, on April 28, 2026, sold 1,557 shares in Travelers Companies (TRV) for $483,670. Following the Form 4 filing with the SEC, Heyman has control over a total of 263,819 common shares of the company, with 259,590 shares held directly and 4,229 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/86312/000008631226000120/xslF345X05/form4.xml

$TRV

Insider Trading146d ago

Waste Connections Insider Sold Shares Worth $427,168, According to a Recent SEC Filing

James Little, Executive Vice President, Engineering, on April 27, 2026, sold 2,605 shares in Waste Connections (WCN) for $427,168. Following the Form 4 filing with the SEC, Little has control over a total of 48,436 common shares of the company, with 34,395 shares held directly and 14,041 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1318220/000113041626000004/xslF345X05/primarydocument.xml

$WCN

Insider Trading146d ago

Interactive Brokers Group Insider Sold Shares Worth $2,000,180, According to a Recent SEC Filing

Lawrence E Harris, Director, on April 28, 2026, sold 26,000 shares in Interactive Brokers Group (IBKR) for $2,000,180. Following the Form 4 filing with the SEC, Harris has control over a total of 173,482 Class A common shares of the company, with 173,482 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1381197/000138119726000086/xslF345X05/ownership.xml

$IBKR

Insider Trading146d ago

Fifth Third Bancorp Insider Sold Shares Worth $1,009,189, According to a Recent SEC Filing

Peter L Sefzik, Executive Vice President, on April 28, 2026, sold 20,000 shares in Fifth Third Bancorp (FITB) for $1,009,189. Following the Form 4 filing with the SEC, Sefzik has control over a total of 189,382 common shares of the company, with 189,382 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/35527/000003552726000174/xslF345X05/wk-form4_1777492921.xml

$FITB

Insider Trading146d ago

Credo Technology Group Holding Insider Sold Shares Worth $4,931,442, According to a Recent SEC Filing

Chi Fung Cheng, Director, Chief Technology Officer, on April 27, 2026, sold 27,500 shares in Credo Technology Group Holding (CRDO) for $4,931,442. Following the Form 4 filing with the SEC, Cheng has control over a total of 6,161,156 ordinary shares of the company, with 108,786 shares held directly and 6,052,370 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1807794/000162828026028331/xslF345X05/wk-form4_1777492236.xmlPrice: $174.84, Change: $+8.92, Percent Change: +5.37%

$CRDO

Showing 4101-4120 of 4507